Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mucodentol
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
Mucodentol is a mucoadhesive, sustained-release oral paste developed for local application in the oral cavity. It is designed to adhere to the mucosal surfaces and provide prolonged release of its active components. The primary indication appears to be for prevention or management of symptoms related to viral infections such as COVID-19, particularly in non-infected individuals exposed within households[2][4]. Its mechanism likely involves forming a protective barrier on the oral mucosa, potentially reducing viral entry or replication locally. The exact active ingredients and detailed mechanism are not specified in available sources.
- Brand names
- Mucodentol
- Other names
- Mucodentol
Beyond the preview
Go deeper on Mucodentol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mucodentol.